Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Nephro Care IPO is a book build issue of ₹41.26 crores. The issue is entirely a fresh issue of 0.46 crore shares of ₹41.26 crore.
Nephro Care IPO bidding started from Jun 28, 2024 and ended on Jul 2, 2024. The allotment for Nephro Care IPO was finalized on Jul 3, 2024. The shares got listed on NSE SME on Jul 5, 2024.
Nephro Care IPO price band is set at ₹90.00 per share . The lot size for an application is 1,600. The minimum amount of investment required by an retail is ₹1,36,000 (1600 shares). The minimum lot size investment for HNI is 2 lots (3,200 shares), amounting to ₹2,88,000.
The issue includes a reservation of up to 2,25,600 shares for employees offered at a discount of ₹0.00 to the issue price.
Corporate Capitalventures Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is SS Corporate Securities Ltd..
Refer to Nephro Care IPO RHP for detailed Information.
| IPO Date | June 28, 2024 to July 2, 2024 |
| Listing Date | July 5, 2024 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹85 to ₹90 per share |
| Issue Price Final | ₹90 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 45,84,000 shares (aggregating up to ₹41.26 Cr) |
| Reserved for Market Maker | 2,30,400 shares SS Corporate Securities Ltd. (aggregating up to ₹2.07 Cr) |
| Net Offered to Public | 43,53,600 shares (aggregating up to ₹39.18 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,19,02,400 shares |
| Share Holding Post Issue | 1,64,86,400 shares |
Nephro Care India IPO offers total 45,84,000 shares. Out of which 20,64,000 (45.03%) allocated to QIB, 8,25,600 (18.01%) allocated to QIB, 6,19,200 (13.51%) allocated to NII, 14,44,800 (31.52%) allocated to RII and 12,38,400 (27.02%) allocated to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 2,30,400 (5.03%) |
| QIB Shares Offered | 20,64,000 (45.03%) |
| − Anchor Investor Shares Offered | 12,38,400 (27.02%) |
| − QIB (Ex. Anchor) Shares Offered | 8,25,600 (18.01%) |
| NII (HNI) Shares Offered | 6,19,200 (13.51%) |
| Retail Shares Offered | 14,44,800 (31.52%) |
| Employee Shares Offered | 2,25,600 (4.92%) |
| Total Shares Offered | 45,84,000 (100.00%) |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only NII | Above Rs 2 Lakhs | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Nephro Care IPO raises ₹11.15 crore from anchor investors. Nephro Care IPO Anchor bid date is June 27, 2024. Nephro Care IPO Anchor Investors list
| Bid Date | June 27, 2024 |
| Shares Offered | 12,38,400 |
| Anchor Portion Size (In Cr.) | 11.15 |
| Anchor lock-in period end date for 50% shares (30 Days) | August 2, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | October 1, 2024 |
Nephro Care IPO opens on June 28, 2024, and closes on July 2, 2024.
| IPO Open Date | Fri, Jun 28, 2024 |
| IPO Close Date | Tue, Jul 2, 2024 |
| Tentative Allotment | Wed, Jul 3, 2024 |
| Initiation of Refunds | Thu, Jul 4, 2024 |
| Credit of Shares to Demat | Thu, Jul 4, 2024 |
| Tentative Listing Date | Fri, Jul 5, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on Tue, Jul 2, 2024 |
Investors can bid for a minimum of 1,600 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,44,000 |
| Retail (Max) | 1 | 1,600 | ₹1,44,000 |
| HNI (Min) | 2 | 3,200 | ₹2,88,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center located in Kolkata, offering a wide range of clinical and lifestyle solutions, as well as renal insufficiency treatment for patients.
Nephro Care is supported by expert doctors, experienced paramedical professionals, and a skilled management team.
Currently, the hospital provides healthcare services to approximately 900 Chronic Kidney Disease patients every month. The hospital has 5 permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals. These services are delivered from its main Salt Lake clinic, which covers an area of 5,352 square feet, and three satellite clinics located in Salt Lake (HB 113) and Chandannagar, West Bengal.
At present, Nephro Care offers the following services at its clinics:
As of March 31, 2024 the hospital employs 110 people in various departments.
Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 2,029.85 | 831.11 | 462.93 | 112.84 |
| Total Income | 1,989.60 | 1,709.51 | 342.70 | 183.26 |
| Profit After Tax | 340.04 | 194.24 | -0.98 | 8.87 |
| Net Worth | 1,392.32 | 243.76 | 49.52 | 1.50 |
| Reserves and Surplus | 1,332.81 | 193.76 | -0.48 | 0.50 |
| Total Borrowing | 246.39 | 253.74 | 69.27 | |
| Amount in ₹ Lakhs | ||||
The market capitalization of Nephro Care IPO is ₹148.38 Cr.
KPI as of Sun, Dec 31, 2023.
| KPI | Values |
|---|---|
| ROE | 41.57% |
| ROCE | 36.56% |
| RoNW | 24.42% |
| PAT Margin | 17.22% |
| Price to Book Value | 8.04 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 1.63 | 2.75 |
| P/E (x) | 55.15 | 32.73 |
The company intends to utilize the Net Fresh Issue Proceeds for the following Objects
[Dilip Davda] The company is engaged in providing healthcare services with renal insufficiency treatment. It marked inconsistency in its net earnings for the reported periods and the sudden surge in bottom in for 9M-FY24 raise eyebrows and concern over its sustainability going forward. Based on its super annualized FY24 earnings, the issue appears aggressively priced. There is no harm in skipping this pricey bet. Read detail review...
| Listing Date | July 5, 2024 |
| BSE Script Code | |
| NSE Symbol | NEPHROCARE |
| ISIN | INE0SUN01013 |
| Final Issue Price | ₹90 per share |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹90.00 |
| Open | ₹171.00 |
| Low | ₹171.00 |
| High | ₹179.55 |
| Last Trade | ₹179.55 |
Nephro Care India Ltd.
Flat No-1JC-18, 5th Floor Sec-III
Salt lake Kolkata, Bidhan Nagar Sai Complex,
North 24 Parganas
Kolkata, West Bengal, 700098
Phone: +91 8017010197
Email: cs@nephrocareindia.com
Website: https://www.nephrocareindia.com/
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Nephro Care IPO is a SME IPO of 45,84,000 equity shares of the face value of ₹10 aggregating up to ₹41.26 Crores. The issue is priced at ₹90 per share. The minimum order quantity is 1600.
The IPO opens on June 28, 2024, and closes on July 2, 2024.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Nephro Care IPO using UPI as a payment gateway. Zerodha customers can apply in Nephro Care IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Nephro Care IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Nephro Care IPO opens on June 28, 2024 and closes on July 2, 2024.
Nephro Care IPO lot size is 1600, and the minimum amount required for application is ₹1,44,000.
You can apply in Nephro Care IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Nephro Care IPO will be done on Wednesday, July 3, 2024, and the allotted shares will be credited to your demat account by Thursday, July 4, 2024. Check the Nephro Care IPO allotment status.
The Nephro Care IPO listing date is on Friday, July 5, 2024.
Useful Articles
RHP